AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pleural Neoplasm

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site๐Ÿ“ Chicago University of Chicago ยท Tests: Partial Pleurectomy Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai๐Ÿ“ Chengdu Ruijin Hospital ยท Tests: Ivonescimab Combined With Chemotherapy NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study NCT07121374Phase 1, Phase 21 site๐Ÿ“ Edegem University Hospital, Antwerp ยท Tests: Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites๐Ÿ“ Denver๐Ÿ“ Chicago๐Ÿ“ Grand Rapids Context Therapeutics Inc. ยท Tests: CT-95 Safety and Efficacy of NK510 to Treat NSCLC NCT06097962EARLY Phase 11 site๐Ÿ“ Nanjing Base Therapeutics (Shanghai) Co., Ltd. ยท Tests: NK510, Tislelizumab๏ผŒatezolizumab or sugemalimab, NK510, systemic therapy as selected by the investigator A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites๐Ÿ“ Goodyear๐Ÿ“ Phoenix๐Ÿ“ Duarte IDEAYA Biosciences ยท Tests: IDE892, IDE397 Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma NCT05765084Phase 1, Phase 23 sites๐Ÿ“ Edegem๐Ÿ“ Ghent๐Ÿ“ Sint-Niklaas University Hospital, Antwerp ยท Tests: Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG NCT06959719NA1 site๐Ÿ“ Cambridge Cambridge University Hospitals NHS Foundation Trust ยท Tests: Air Entrainment - intentional introduction of the atmospheric air into the pleural space. Safety and Feasibility of Medical Thoracoscopy Using Single-use Flexible Bronchoscope Versus SemiRigid Pleuroscope in Pleural Effusion NCT07726784NA2 sites๐Ÿ“ Kuala Lumpur๐Ÿ“ Cheras National University of Malaysia ยท Tests: Single-Use Flexible Bronchoscope, Semi-Rigid Pleuroscope Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study. NCT04806412NA1 site๐Ÿ“ Nรฆstved Naestved Hospital ยท Tests: meassurement of PD-L1, ALK, EGFR Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion NCT06184321EARLY Phase 12 sites๐Ÿ“ Baltimore๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Alteplase, Placebo Administration Olaparib in Patients With HRD Malignant Mesothelioma NCT04515836Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Olaparib SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites๐Ÿ“ Tampa๐Ÿ“ Westwood๐Ÿ“ Philadelphia Verismo Therapeutics ยท Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion NCT06740019Phase 11 site๐Ÿ“ Beijing Jemincare ยท Tests: JMKX000197, Tube thoracostomy drainage UNC Pleural Fluid Registry NCT05620329n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors NCT07443020Phase 11 site๐Ÿ“ Pittsburgh Allegheny Singer Research Institute (also known as Alleghenโ€ฆ ยท Tests: locally manufactured adoptive cellular therapy (ACT) product, Interleukin-2 (IL-2) Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS NCT06886672n/a2 sites๐Ÿ“ Pavia๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer NCT06658080n/a3 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: organoid drug test Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) NCT04996017Phase 319 sites๐Ÿ“ Meldola๐Ÿ“ Alessandria๐Ÿ“ Bari Gruppo Oncologico Italiano di Ricerca Clinica ยท Tests: Atezolizumab 1200 mg in 20 ML Injection, Placebo TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO NCT05628376n/a1 site๐Ÿ“ London University College, London A Study of MT027 in Patients with Pleural Malignant Tumors NCT06726564Phase 11 site๐Ÿ“ Beijing Suzhou Maximum Bio-tech Co., Ltd. ยท Tests: MT027 cells suspension A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Enzalutamide TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites๐Ÿ“ Camperdown๐Ÿ“ Malvern๐Ÿ“ Nedlands Treeline Biosciences, Inc. ยท Tests: TLN-499, Venetoclax Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases NCT05477927Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: Dual-targeting VEGFR1/PD-L1 CAR-T cells Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO) NCT06637345n/a1 site๐Ÿ“ Aviano Centro di Riferimento Oncologico - Aviano Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer NCT00033137n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935Phase 213 sites๐Ÿ“ Chicago๐Ÿ“ Ann Arbor๐Ÿ“ St Louis Memorial Sloan Kettering Cancer Center ยท Tests: Pemetrexed, Cisplatin, Carboplatin SW-682 in Advanced Solid Tumors NCT06251310Phase 18 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Sacramento SpringWorks Therapeutics, Inc., a healthcare company of Merโ€ฆ ยท Tests: SW-682, Combination Therapy Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients NCT07012759n/a1 site๐Ÿ“ New Taipei City Fu Jen Catholic University ยท Tests: biomarkers
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy